Cost-effectiveness Evaluation of Two 10% Urea Creams in Patients With Diabetic Foot Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 31, 2022

Conditions
Diabetic Foot
Interventions
OTHER

Participants were given the 10% urea cream purchased in pharmacy or supermarket as appropriate after randomisation and their foot skin quality was assessed by validated questionnaire.

Participants agreed to the interventions after allocation to each arm according to randomisation and after signing an informed consent form. The creams tested in this study provided to participants are authorised for sale within the European Union but are not considered drugs or medical devices. The main purpose of the interventions was based on the care and assessment of the quality of the skin of the participants' feet.

Trial Locations (1)

28040

José Luis Lázaro Martínez, Madrid

All Listed Sponsors
lead

Universidad Complutense de Madrid

OTHER

NCT05588258 - Cost-effectiveness Evaluation of Two 10% Urea Creams in Patients With Diabetic Foot Syndrome | Biotech Hunter | Biotech Hunter